UnitedHealth Group Incorporated
UNH Healthcare Medical - Healthcare Plans NYSE
$291.48
+$8.78 (+3.11%)
Open: $283.72 | High: $292.82 | Low: $283.72 | Prev Close: $282.70
Market Cap: $264.03B
Volume: 11.7M | Avg: 8.3M
Last updated: January 28, 2026 at 04:06 PMFeatured In
This stock appears in the following dashboards:
Investment Rating
Neutral
Overall Score: 60/100
Rating Breakdown:
Stock Score Analysis
Stock Score: 425
Comprehensive Quality Assessment
Component Breakdown:
Valuation Metrics
| P/E Ratio | 15.18 |
| P/B Ratio | 2.65 |
| P/S Ratio | 0.59 |
| EPS | $19.20 |
| Beta | 0.43 |
| Shares Outstanding | 905.84M |
| 52-Week High | $606.36 |
| 52-Week Low | $234.60 |
| SMA 50 | $331.47 |
| SMA 200 | $333.72 |
| Dividend Yield | 3.00% |
| Annual Dividend | $8.73 |
| Next Earnings | April 16, 2026 04:00 AM ET |
Financial Ratios
| Gross Margin | 18.5% |
| Operating Margin | 4.2% |
| Net Margin | 3.2% |
| ROE | 14.8% |
| ROA | 4.6% |
| Debt/Equity | 0.78 |
| Current Ratio | 0.79 |
| Quick Ratio | 0.79 |
Balance Sheet
| Total Assets | $309.58B |
| Total Liabilities | $207.88B |
| Total Equity | $100.09B |
|
|
|
| Cash | $28.12B |
| Total Debt | $78.39B |
| Net Debt | $50.27B |
Income Statement
| Revenue | $447.57B |
| Gross Profit | $82.92B |
| Operating Income | $18.96B |
| Net Income | $14.23B |
|
|
|
| EBITDA | $23.19B |
| Revenue/Share | $491.83 |
Cash Flow
| Operating CF | $38.29B |
| CapEx | $6.30B |
| Free Cash Flow | $31.99B |
|
|
|
| Book Value/Share | $111.76 |
| Tangible Book/Share | $111.76 |
| Equity/Share | $109.99 |
Technical Indicators
| RSI (14) | 31.56 Neutral |
| MACD |
-4.06
Signal: 1.06
|
| Volatility | 61.42% |
| Trading Signal | Bearish |
Performance & Returns
| 1 Year | -50.96% |
| Sharpe Ratio | -1.46 Poor |
| Volatility (Ann.) | 54.73% High Risk |
| UNH (1Y) | -50.96% |
| S&P 500 (1Y) | +32.51% |
| Alpha (Excess Return) | -83.47% |
Sector Comparison (Healthcare)
| Metric | UNH | Sector Avg | Percentile |
|---|---|---|---|
| P/E Ratio | 15.18 | 33.57 | 21% |
| P/B Ratio | 2.65 | -1.17 | 42% |
| ROE (%) | 14.76% | 7.53% | 54% |
| Net Margin (%) | 3.18% | 9.54% | 25% |
| Stock Score | 425 | 493.0 | 12% |
| 1Y Return (%) | -50.96 % | +19.85 % | 2% |
📊 Historical Price Analysis (Last 200 Days)
Loading chart...
Technical Analysis
| Ticker | Close | SMA 5 | SMA 8 | SMA 13 | SMA 50 | SMA 200 | RSI (14) | MACD | Volatility (%) | Volume | Signal | SMA Decision |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UNH | $291.48 | $327.47 | $331.82 | $334.38 | $330.67 | $332.21 | 31.56 | -4.06 | 61.42% | 11457812 | Strong Short | Bearish Stack |
Candlestick Patterns
There wasn't any recognizable pattern for the UNH stock
News Sentiment
| 📊 Ticker | 📰 Headline | 💭 Sentiment | 📡 Source | 🔗 URL |
|---|---|---|---|---|
| UNH | How Low Can UNH Stock Go? | Neutral | forbes.com | Read More |
| UNH | UnitedHealth Q4 Earnings Review: The Selloff Looks Overdone After Results | Neutral | seekingalpha.com | Read More |
| UNH | UNH Stock: Why Did The Healthcare Giant Stumble? | Neutral | forbes.com | Read More |
| UNH | Belpointe Asset Management LLC Sells 2,118 Shares of UnitedHealth Group Incorporated $UNH | Neutral | defenseworld.net | Read More |
| UNH | These 3 U.S. politicians suspiciously dumped UnitedHealth stock weeks before crash | Neutral | finbold.com | Read More |
Recent Insider Trading
No recent insider trading data available for UNH
Company Information
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals directly through care delivery systems, employers, payers, and government entities. The OptumInsight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota.
| CEO | Stephen J. Hemsley |
| Employees | 400000 |
| Country | US |
| IPO Date | 1984-10-17 |
| Exchange | NYSE |
| Website | https://www.unitedhealthgroup.com |
| Sector | Healthcare |
| Industry | Medical - Healthcare Plans |
Similar Stocks (Healthcare - Medical - Healthcare Plans)
Rating Metrics Explained
DCF Score (Discounted Cash Flow)
Measures the intrinsic value of the stock based on projected future cash flows. A higher score indicates the stock is undervalued relative to its DCF valuation.
ROE Score (Return on Equity)
Evaluates how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better profitability and management effectiveness.
ROA Score (Return on Assets)
Measures how efficiently a company uses its assets to generate profit. A higher ROA means better asset utilization and operational efficiency.
D/E Score (Debt-to-Equity)
Assesses the company's financial leverage and risk. Lower debt-to-equity ratios indicate less financial risk and better balance sheet health.
P/E Score (Price-to-Earnings)
Compares stock price to earnings per share. A lower P/E ratio may indicate the stock is undervalued, while a higher ratio could suggest overvaluation or growth expectations.
P/B Score (Price-to-Book)
Compares market price to book value per share. Lower P/B ratios may indicate undervaluation relative to the company's net asset value.
Rating Recommendations:
Each metric is scored on a scale of 1-5, where the scores are determined by comparing the company's performance against industry benchmarks and historical data:
-
Strong Buy (5/5): Excellent score - strong positive indicator
- The metric significantly outperforms industry averages (top 20% of companies)
- Indicates exceptional financial health or attractive valuation in that category
-
Buy (4/5): Good score - positive indicator
- Above-average performance (top 40% of companies)
- Shows strong fundamentals with room for improvement
-
Neutral (3/5): Average score - neutral indicator
- Performance in line with industry median (middle 20%)
- Neither significantly positive nor negative signal
-
Sell (2/5): Below average - negative indicator
- Below-average performance (bottom 40% of companies)
- Suggests weakness in this particular metric
-
Strong Sell (1/5): Poor score - strong negative indicator
- Significantly underperforms industry (bottom 20%)
- Indicates potential risk or overvaluation in that category